HepaGam B (hepatitis B immune globulin intravenous (human)) / Kamada  >>  Phase 4
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
HepaGam B (hepatitis B immune globulin intravenous (human)) / Kamada
NCT00998426: Evaluating Blood Glucose Levels During Infusion With HepaGam B (HBIG) in Post-liver Transplant Patients

Completed
4
5
US
glucose monitoring before and after HepaGam B administration, HepaGam B, Hepatitis B Immune Globulin, HepaGam B (Hepatitis B Immune Globulin (HBIG))
Georgetown University, Cangene Corporation
Hepatitis B
09/11
12/11
NCT00722332: Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients

Completed
4
9
US, Canada
HepaGam B
Cangene Corporation
Hepatitis B, Liver Transplantation
10/13
10/13

Download Options